Document:

NEITHER THIS SECURITY NOR THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE OR UNDER THE SECURITIES ACT OF 1933, AS AMENDED.  THE SECURITIES ARE RESTRICTED AND MAY NOT BE OFFERED, RESOLD, PLEDGED OR TRANSFERRED EXCEPT AS PERMITTED UNDER THE ACT PURSUANT TO REGISTRATION OR EXEMPTION OR SAFE HARBOR THEREFROM. 

			
	No.

	___________

	US $105,834.00

ACCELPATH, INC.

CONVERTIBLE PROMISSORY NOTE DUE SEPTEMBER 1, 2013

THIS Note is a duly authorized issuance of up to $500,000.00 of ACCELPATH, INC., a Delaware corporation and located at 352A Christopher Avenue, Gaithersburg, MD 20879 (the "Company") designated as its July 2012 Convertible Note, pursuant to that certain Exchange Agreement between the Company and Holder of even date. 

FOR VALUE RECEIVED, the Company promises to pay to SOUTHRIDGE PARTNERS II, LP, the registered holder hereof (the "Holder"), the principal sum of One Hundred Five Thousand Eight Hundred Thirty Four and 00/100 Dollars (US $105,834.00), plus accrued interest in the amount of five percent (5%) per annum on all outstanding principal on September 1, 2013 (the “Maturity Date”). The Company will pay the outstanding principal amount of this Note, plus accrued interest, in cash on the Maturity Date to the registered holder of this Note.  The wire transfer of such amount shall constitute a payment hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by wire transfer plus any amounts so deducted.

This Note is subject to the following additional provisions:

1.

The Note is issuable in denominations of Ten Thousand Dollars (US$10,000) and integral multiples thereof, provided that the number of shares to be issued upon conversion is a minimum of 3,000 (unless if at the time of election to convert the number of shares of Common Stock issuable upon conversion is less than 3,000).  The Note is exchangeable for an equal aggregate principal amount of Note of different authorized denominations, as requested by the Holder surrendering the same.  No service charge will be made for such registration or transfer or exchange.

2.

The Holder of this Note is entitled at any time at its option to convert all or a portion of the principal amount of this Note plus accrued interest into shares of Common Stock at a conversion price for each share of Common Stock equal to the Current Market Price multiplied by sixty percent (60%) (the “Conversion Price”). “Current Market Price” means the average of the two (2) lowest closing bid prices for the Common Stock as reported by Bloomberg, LP or, if not so

1

reported, as reported on the over-the-counter market, for the five (5) trading days ending on the trading day immediately before the relevant Conversion Date (as defined below).  The amount of shares issuable pursuant to a conversion shall equal the principal amount (or portion thereof) of the Note to be converted, plus accrued interest, divided by the Conversion Price.

Conversion shall be effectuated by surrendering the Note to the Company, accompanied by or preceded by facsimile or other delivery to the Company of the form of conversion notice attached hereto as Exhibit A, executed by the Holder evidencing such Holder's intention to convert a specified portion hereof.  No fractional shares of Common Stock or scrip representing fractions of shares will be issued on conversion, but the number of shares issuable shall be rounded to the nearest whole share.  The date on which notice of conversion is given (the "Conversion Date") shall be deemed to be the date on which the Holder faxes or otherwise delivers the conversion notice ("Notice of Conversion"), substantially in the form annexed hereto as Exhibit A, duly executed, to the Company.  Facsimile delivery of the Notice of Conversion shall be accepted by the Company at facsimile number (   ) __________________ ATTN: President.  Certificates representing Common Stock upon conversion will be delivered within five (5) business days from the Conversion Date. (“Delivery Date”)

The Company understands that a delay in the issuance of the Shares of Common Stock beyond the Delivery Date (as defined in this Section) could result in economic loss to the Holder.  As compensation to the Holder for such loss, the Company agrees to pay late payments to the Holder for late issuance of Shares upon Conversion, unless the delay is due to causes beyond the reasonable control of the Company or the Transfer Agent, in accordance with the following schedule (where “No. Business Days Late” refers to the number of business days which is beyond three (3)) business days after the Delivery Date):1

							
	 
	No. Business Days Late

	 
	Late Payment For Each $10,000

of Note Principal or Interest

Amount Being Converted

	 

	 
	 
	 
	 
	 
	 
	 

	 
	 
	1

	 
	 
	$100

	 

	 
	 
	2

	 
	 
	$200

	 

	 
	 
	3

	 
	 
	$300

	 

	 
	 
	4

	 
	 
	$400

	 

	 
	 
	5

	 
	 
	$500

	 

	 
	 
	6

	 
	 
	$600

	 

	 
	 
	7

	 
	 
	$700

	 

	 
	 
	8

	 
	 
	$800

	 

	 
	 
	9

	 
	 
	$900

	 

	 
	 
	10

	 
	 
	$1,000

	 

	 
	 
	>10

	 
	 
	$1,000 +$200 for each Business

	 
	 
	 
	 
	 
	Day Late beyond 10 days

		
	 
	 

2

The Company shall pay any payments incurred under this Section in immediately available funds upon demand as the Holder’s remedy for such delay.  Furthermore, in addition to any other remedies which may be available to the Holder, in the event that the Company fails for any reason to effect delivery of such shares of Common Stock by close of business on the Delivery Date, unless such failure is due to causes beyond the Company’s reasonable control or that of its Transfer Agent,  the Holder will be entitled to revoke the relevant Notice of Conversion by delivering a notice to such effect to the Company, whereupon the Company and the Holder shall each be restored to their respective positions immediately prior to delivery of such Notice of Conversion; provided, however, that an amount equal to any payments contemplated by this Section which have accrued through the date of such revocation notice shall remain due and owing to the Converting Holder notwithstanding such revocation.  

In lieu of delivering physical certificates representing the Common Stock issuable upon conversion, provided the Company’s Transfer Agent is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer program, upon request of the Holder and its compliance with the provisions contained in this paragraph, so long as the certificates therefore do not bear a legend and the Holder thereof is not obligated to return such certificate for the placement of a legend thereon, the Company shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder by crediting the account of Holder’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission system.

The Holder of the Note shall be entitled to exercise its conversion privilege with respect to the Note notwithstanding the commencement of any case under 11 U.S.C. §101 et seq. (the “Bankruptcy Code”).  In the event the Company is a debtor under the Bankruptcy Code, the Company hereby waives, to the fullest extent permitted, any rights to relief it may have under 11 U.S.C. §362 in respect of such holder’s conversion privilege.  The Company hereby waives, to the fullest extent permitted, any rights to relief it may have under 11 U.S.C. §362 in respect of the conversion of the Note.  

3.

The Company shall be entitled to withhold from all payments of principal of this Note any amounts required to be withheld under the applicable provisions of the United States income tax laws or other applicable laws at the time of such payments, and Holder shall execute and deliver all required documentation in connection therewith.

4.

This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended (the "Act"), and other applicable state and foreign securities laws.  

5.

No provision of this Note shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of this Note at the time, place, and rate, and in the coin or currency, herein prescribed.  This Note is a direct obligation of the Company.

3

6.

Presentment.  Except as set forth herein, the Company waives presentment, demand and presentation for payment, notice of nonpayment and dishonor, protest and notice of protest and expressly agrees that this Note or any payment hereunder may be extended from time to time by the Holder without in any way affecting the liability of the Company.

7.

Maximum Rate.  All provisions herein made are expressly limited so that in no event whatsoever, whether by reason of advancement of proceeds hereof, acceleration of maturity of the unpaid balance hereof or otherwise, shall the amount paid or agreed to be paid to Holder for the use of the money advanced or to be advanced hereunder exceed the maximum rate of interest allowed to be charged under applicable law (the “Maximum Rate”), regardless of whether or not there has been an acceleration of the payment of principal as set forth herein. If, from any circumstances whatsoever, the fulfillment of any provision of this Note or any other agreement or instrument now or hereafter evidencing, securing or in any way relating to the indebtedness evidenced hereby shall involve the payment of interest in excess of the Maximum Rate, then, ipso facto, the obligation to pay interest hereunder shall be reduced to the Maximum Rate; and if from any circumstance whatsoever, Holder shall ever receive interest, the amount of which would exceed the amount collectible at the Maximum Rate, such amount as would be excessive interest shall be applied to the reduction of the principal balance remaining unpaid hereunder and not to the payment of interest. This provision shall control every other provision in any and all other agreements and instruments existing or hereafter arising between the Maker and Holder with respect to the indebtedness evidenced hereby. 

8.

This Note shall be governed by and construed in accordance with the laws of the State of New York.  Each of the parties consents to the jurisdiction of the federal courts whose districts encompass any part of the City of New York or the state courts of the State of New York sitting in the City of New York in connection with any dispute arising under this Note and hereby waives, to the maximum extent permitted by law, any objection, including any objection based on forum non coveniens, to the bringing of any such proceeding in such jurisdictions. Each of the parties hereby waives the right to a trial by jury in connection with any dispute arising under this Note.

9.

The following shall constitute an "Event of Default":

a.

The Company shall default in the payment of principal and interest on this Note and same shall continue for a period of five (5) days; or

b.

Any of the representations or warranties made by the Company herein, in any certificate or financial or other written statements heretofore or hereafter furnished by the Company in connection with the execution and delivery of this Note shall be false or misleading in any material respect at the time made; or

4

c.

The Company shall fail to perform or observe, in any material respect, any other covenant, term, provision, condition, agreement or obligation of any Note and such failure shall continue uncured for a period of thirty (30) days after written notice from the Holder of such failure; or

d.

The Company fails to authorize or to cause its Transfer Agent to issue shares of Common Stock upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of this Note, fails to transfer or to cause its Transfer Agent to transfer any certificate for shares of Common Stock issued to the Holder upon conversion of this Note and when required by this Note, and such transfer is otherwise lawful, or fails to remove any restrictive legend on any certificate or fails to cause its Transfer Agent to remove such restricted legend, in each case where such removal is lawful, as and when required by this Note, the Agreement, and any such failure shall continue uncured for ten (10) business days; or

e.

The Company shall (1) admit in writing its inability to pay its debts generally as they mature; (2) make an assignment for the benefit of creditors or commence proceedings for its dissolution; or (3) apply for or consent to the appointment of a trustee, liquidator or receiver for its or for a substantial part of its property or business; or

f.

A trustee, liquidator or receiver shall be appointed for the Company or for a substantial part of its property or business without its consent and shall not be discharged within sixty (60) days after such appointment; or

g.

Any governmental agency or any court of competent jurisdiction at the instance of any governmental agency shall assume custody or control of the whole or any substantial portion of the properties or assets of the Company and shall not be dismissed within sixty (60) days thereafter; or

h.

Any money judgment, writ or warrant of attachment, or similar process in excess of One Hundred Fifty Thousand ($150,000) Dollars in the aggregate shall be entered or filed against the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of sixty (60) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

i.

Bankruptcy, reorganization, insolvency or liquidation proceedings or other proceedings for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Company and, if instituted against the Company, shall not be dismissed within sixty (60) days after such institution or the Company shall by any action or answer approve of, consent

5

to, or acquiesce in any such proceedings or admit the material allegations of, or default in answering a petition filed in any such proceeding; or

j.

The Company shall have its Common Stock suspended or delisted from an exchange or over-the-counter market from trading for in excess of five trading days.

Then, or at any time thereafter, and in each and every such case, unless such Event of Default shall have been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option of the Holder and in the Holder's sole discretion, the Holder may consider all obligations under this Note immediately due and payable within five (5) days of notice, without presentment, demand, protest or notice of any kinds, all of which are hereby expressly waived, anything herein or in any note or other instruments contained to the contrary notwithstanding, and the Holder may immediately enforce any and all of the Holder's rights and remedies provided herein or any other rights or remedies afforded by law.

Collection.  In the event this Note is placed by Holder in the hands of an attorney for collection, or if Holder incurs any costs incident to the collection of the indebtedness evidenced hereby, the Company agrees to pay to Holder an amount equal to all such costs, including without limitation all reasonable attorneys' fees and all court costs.

10.

The Holder may not convert this Note to the extent such conversion would result in the Holder, together with any affiliate thereof, beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act and the rules promulgated thereunder) in excess of 9.999% of the then issued and outstanding shares of Common Stock held by such Holder after application of this Section.  Since the Holder will not be obligated to report to the Company the number of shares of Common Stock it may hold at the time of a conversion hereunder, unless the conversion at issue would result in the issuance of shares of Common Stock  in excess of 9.999% of the then outstanding shares of Common Stock without regard to any other shares which may be beneficially owned by the Holder or an affiliate thereof, the Holder shall have the authority and obligation to determine whether the restriction contained in this Section will limit any particular conversion hereunder and to the extent that the Holder determines that the limitation contained in this Section applies, the determination of which portion of the principal amount of Note are convertible shall be the responsibility and obligation of the Holder.  If the Holder has delivered a Conversion Notice for a principal amount of Note that would result in the issuance of in excess of the permitted amount hereunder, without regard to any other shares that the Holder or its affiliates may beneficially own, the Company shall notify the Holder of this fact and shall honor the conversion for the maximum principal amount permitted to be converted on such Conversion Date and, at the option of the Holder, either retain any principal amount tendered for conversion in excess of the permitted amount hereunder for future conversions or return such excess principal amount to the Holder.  The provisions of this Section may be waived by a Holder (but only as to itself and not to any other Holder) upon not less than 65 days prior notice to the Company. Other Holders shall be unaffected by any such waiver.

6

11.

Nothing contained in this Note shall be construed as conferring upon the Holder the right to vote or to receive dividends or to consent or receive notice as a shareholder in respect of any meeting of shareholders or any rights whatsoever as a shareholder of the Company, unless and to the extent converted in accordance with the terms hereof.

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed by an officer thereunto duly authorized.

Dated: July 18, 2012

			
	 
	ACCELPATH, INC. 

	 
	 
	 

	 
	By:

	/s/Shekhar Wadekar

	 
	 
	 

	 
	Shekhar Wadekar

	 
	Chief Executive Officer

			
	ATTESTOR

	 

	 
	 
	 

	By:

	 
	 

7ex10-1.htm

Exhibit 10.1

 

 

PARTICULARS OF AN AGREEMENT BETWEEN ROBERTSON TECHNOLOGIES LICENSING LLC, A NEVADA LIMITED LIABILITY COMPANY,  ROBERTSON WELLNESS, LLC, BOTH OF P.O. Box 5856, SAGINAW, MI  48603-1273, TEL +001 989 799 8720, (“COLLECTIVELY ROBERTSON”), AND THE FOUNDATION FOR PROFESSIONAL DEVELOPMENT PTY. LTD (REGISTRATION NUMBER 2000/002641/07) ON CO-OPERATION IN DEVELOPING AND PRESENTING SOFTWARE TOOLS AND COURSES FOR THE HEALTHCARE INDUSTRY

The following constitutes the Heads of Agreement between Robertson and the Foundation for Professional Development Pty. Ltd. (hereinafter referred to as “The Foundation”), as related to the co-operation in developing and presenting software tools and courses for the healthcare industry.

	
1. 

	
DURATION

It is agreed that the parties will commence working together to achieve the purpose as set out below as from the date of signature by both parties of this Agreement and for three consecutive years thereafter. After the initial period, the agreement will be extended for an additional three year period unless one of the parties terminates the agreement on the grounds as stipulated in clause 8.4 below.

	
2. 

	
PURPOSE

The purpose of this Agreement is for the Robertson and the Foundation to co-operate together for the purposes of developing, compiling, conducting, administering and presenting software tools and courses for the healthcare industry (hereinafter referred to as “software” and “courses” respectively).

	
  

	
2.1

	
Software.  It is proposed that parties collaborate to provide a client for a consumer version of RHealth Advisor which incorporates the disease screening system, disease reference, health record and health tips including first aid guides.  The collaboration would bring the functionality described in more detail below to users of the MXit social media platform.  It is also proposed that the parties collaborate to provide a clinical version of the RHealth Advisor mobile WAP based client of the aforementioned software to qualified medical professionals as determined by the parties.

	
  

	
2.2

	
In summary, the functionality of the application would include:

	
  

	
2.2.1

	
Screening. Users can enter symptoms to guide them (if a clinical professional) to an accurate diagnosis and if permitted suggested treatment or if not permitted a referral onwards to appropriate level of care providers.

	
  

	
2.2.2

	
Reference Guide. Users can search for diseases or symptoms and read more information about them.

	
  

	
2.2.3

	
Health Tips. Users can search current, relevant health tips which are listed by category such as “new mommy”, “teen health”, “first aid” or “men’s health”etc. Users can view daily health tips that are continually updated based on topics that are popular in health at the present time and in general.

	
  

	
2.2.4

	
Health Record. Users can enter their personal health information including demographics, allergy history, immunizations, and more. All the information stored can be utilized during the screening process making the referral even more accurate and customized to the individual.

	
  

	
2.2.5

	
The Foundation and Robertson will work together to ensure that any updates required to the prevalence and treatment publish sets are updated on a bi-yearly basis.  This will entail The Foundation facilitating a 1-3 day workshop with selected medical experts through which content can be reviewed and updated.

 

  

1

  

 

	
  

	
2.2.6

	
Each renewal has a disease set localized to meet the prevalence of disease for the specific demographic, geographic, and climatory factors affecting the patients in their constituency. This regionalized disease set is published for use by the RHealth Advisor suite of applications. Regionalization is done in conjunction with a medical review board established by Robertson and the Foundation to ensure local relevance of diseases, symptoms, and their relative correlation to the region. Robertson will facilitate this process working with an appropriate team of local physicians and medical experts drawn together by the Foundation.  Robertson retains responsibility for approving medical content updates and publishing these updates upon renewal for use by RHealth Advisor per this review process.

	
  

	
2.3

	
Courses.  It is proposed that parties collaborate to provide courses to qualified healthcare professionals relating to Robertson’s Brain Chemistry Optimisation and Performance Enhancement Programs.  This programme is subject to there being sufficient demand for such a training programme.  An overview of these courses can be found in Annexure “C”.

	
3.

	
USE OF TRADE MARKS

	
  

	
3.1

	
The running of software tools and courses provided in terms of this Agreement will be under the auspices of the Foundation and will be marketed under the trade marks of the Foundation only. The participation of Robertson in such software tools and courses will be correctly acknowledged.

	
  

	
3.2

	
The parties may use the trade marks of each other in circumstances where both parties had given prior consent for any marketing to be undertaken in terms of this agreement.

	
4. 

	
DEVELOPMENT OF SOFTWARE TOOLS AND COURSES

	
  

	
4.1

	
The parties agree to co-operate with each other in developing, compiling and customising content and structure appropriate for particular courses agreed upon for the healthcare industry and, further, to co-operate with each other to market, administer, conduct and present the courses.

	
  

	
4.2

	
The parties agree to compile, conduct, market and run such courses as a joint venture and shall provide each other with reasonable assistance and use its best endeavours to maximise the number of courses to be conducted and to procure participants.  Notwithstanding this, the development and conduct of courses shall take place according to a schedule of tasks agreed to by the parties and which is attached to this Agreement, marked Annexures “A” and “B”.

	
  

	
4.3

	
The parties agree to co-operate with each other in customising the software tools content to be suitable for local healthcare professionals and consumers and, further to co-operate with each other to market and administer the software tools.

  

2

  

 

	
5. 

	
CONSIDERATION AND PAYMENT

Courses

	
  

	
5.1

	
Income generated by the running of courses, jointly developed in terms of clause 4 will be held by FPD.  Any expenses incurred by either party shall be in accordance with a budget preapproved by both parties.

	
  

	
5.2

	
Each course will be accounted for separately and the net profits generated by such course will be divided equally between the parties on completion of the course.

	
  

	
5.3

	
Where development costs are incurred for courses jointly developed in terms of clause 4 such costs will be shared equally between the Foundation and Robertson.

	
  

	
5.4

	
FPD shall receive 25% (twenty five percent) of the total gross income generated by such course as an administration fee for the services indicated in annexure B attached hereto.

Software Tools

	
  

	
5.5

	
Income generated through the software tools terms of clause 4 will be held by Robertson.  Any expenses incurred by either party shall be in accordance with a budget preapproved by both parties.

	
  

	
5.6

	
Net profits generated by the software tools will be divided equally between the parties on completion of the course.

	
  

	
5.7

	
Where costs are incurred for the software tools as referred to in clause 4 such costs will be shared equally between the Foundation and Robertson, or in a manner agreed to jointly, such as a third party funding mechanism.

	
  

	
5.8

	
Robertson shall receive 10% (ten percent) of the total gross income generated by such software tools as an administration and support fee.

	
6. 

	
OWNERSHIP

Ownership, Intellectual Property Rights and Copyright of the software tools and contents of courses or material originating in terms of this agreement or improvements made to the Intellectual Property during this agreement will remain with originator at all times during and after termination of the Agreement. Any materials developed jointly by both parties during the course of this Agreement shall be deemed to be shared and no party shall use the material without written consent of both parties.  Products developed by either party prior to or outside of this Agreement will in its original form be exempted from this clause.

	
7. 

	
USAGE OF DEVELOPED COURSES AFTER TERMINATION

Notwithstanding the fact that ownership of the courses is vested in the originating party, after the termination of this Agreement, either party will be able to use all newly developed material pertaining to courses by paying a consideration, as agreed to by the parties..

	
8. 

	
BREACH, ARBITRATION AND TERMINATION

	
  

	
8.1

	
Should a party commit a material breach of any material provision of this agreement and fail to remedy such breach within 14 (fourteen) days of receiving written notice from the other party requiring it to do so, then such other party shall be entitled, without prejudice to its other rights in law, either cancel this agreement or to claim immediate specific performance of all of the defaulting party’s obligations, in either event without prejudice to the aggrieved party’s right to claim damages.

 

  

3

  

	
  

	
8.2

	
In the event of any dispute between the parties relating to the agreement, the parties shall convene a meeting in order to attempt to settle such dispute.  Failing this within a reasonable period, the dispute shall be submitted for arbitration to, and in accordance with, the rules of the Arbitration Foundation of South Africa.

	
  

	
8.3

	
Either party shall be entitled to terminate this agreement by giving the other party not less than six months written notice thereof, provided that no such notice may be given so as to be effective prior to the expiry of the initial duration period as defined in clause 2 above.

	
  

	
8.4

	
Notwithstanding the provisions of clause 8.3, termination of this agreement may be effected only on the grounds of serious non-performance or where there is a material breach of the contract or where one of the parties wishes to withdraw from the business as set out in clause 2 of this agreement, provided that such withdrawal may not be prior to the expiry of the initial duration period as defined in clause 2 above.

	
9. 

	
NOTICE

Any notice to be given or correspondence sent out by the parties to each other shall be at the following addresses, which addresses the parties choose as its domicilium citandi et executandi for purposes of this agreement.

for ROBERTSON

	
ROBERTSON TECHNOLOGIES LICENSING LLC AND ROBERTSON WELLNESS, LLC

Address: P.O. Box 5856, SAGINAW, MI  48603-1273, USA

Tel: +1 989 799 8720

Email: mdecker@robertsonhealth.com

for the FOUNDATION

	
FOUNDATION FOR PROFESSIONAL DEVELOPMENT (PTY) LTD

PO BOX 75324, LYNNWOODRIDGE, 0184 PRETORIA SOUTH AFRICA

TEL +27 12 816 9000

Email: gustaafw@foundation.co.za

Signed at Michigan, USA on this the 19th day of July  2012.

AS WITNESSES:

 

	 
1.

	 
/s/ Melissa Seeger

	 	 
	 	 	 	 
	 
2. 

	/s/ Nicole Decker	/s/ Marcus Decker	 
	 	 	duly authorised representative of Robertson	 

 

  

4

  

Signed at Pretoria South Africa    on this the 18th day of  July   2012.

AS WITNESSES:

 

	 
1.

	 
/s/ .............................................

	 	 
	 	 	 	 
	 
2. 

	/s/ .............................................	/s/ .............................................	 
	 	 	duly authorised representative of the Foundation	 

 

  

5

  

ANNEXURE A

	
 

Responsibility

 

	
 

FPD

	
 

ROBERTSON

	
 

JOINT

	
Course administration

	
X

	  	  
	
Marketing management

	  	  	
X

	
Recruitment of sponsors

	  	  	
X

	
Curriculum development

	  	  	
X

	
Academic Content development

	  	  	
X

	
Study Guide Design, Lay-out and Printing

	
X

	  	  
	
Project Management

	
X

	  	  
	
Assessment Tools Development e.g. Multiple questionnaire

	  	  	
X

	
Workshop Tools Development e.g. case studies, power point presentation

	
X

	  	  
	
Verification, authenticity and accuracy of all information, including:

-Editorial;

-Illustrations;

-Photographs;

-Tables

 

	  	  	
X

	
Accreditation of CPD programme

	
X

	  	  
	
Customer relationships

	  	  	
X

	
Financial management

	
X

	  	  

  

6

  

ANNEXURE B

 

FPD ADMINISTRATIVE COST VERIFICATION

 

COURSE PROJECT PLANNING

 

Identify course dates, venues, faculty and assessor in co-ordination with project manager, course co-ordinator, marketing manager and the FPD program 

Set-up stakeholders information system

Develop marketing schedule with marketing manager

Create softcopy library for course

File all planning material in soft copy library

 

COURSE MASTER FILE

 

Create a master file for course with:

	 
Developed briefing documents to faculty and assessor(Inclusive of request for CV, dates, venue, map, methodology briefing, course outline, contact info of other faculty, invoice specifications)

	 
	
Developed Registration form for students 

Developed “acknowledgement of registration inclusive of course details” letter for participants

Developed certificate for successful participants

Developed course evaluation forms

Developed marketing material

	Hardcopies of all relevant information
	 	 
	COURSE DATABASE 
 

 
Create and maintain a student database in accordance with Council for Higher Education requirements

	§Venue maps 
§Facilitators agreements

§Venue agreements

 

FACULTY AND ASSESSMENT MANAGEMENT

 

Book faculty

Call faculty

Make travel and accommodation arrangements for faculty

Send briefing document to faculty

Book Assessor

Call potential assessor

Fax contract to assessor and faculty

Send briefing document to assessor

Monitor return of CV and Contracts

File CV and contract in course file and soft copy library

 

  

7

  

 

VENUE MANAGEMENT

 

Book venue

Inform venue of requirements (number of students, faculty, staff, etc; registration desk, diets; equipment; classroom layout)

 

MARKETING MANAGEMENT

 

Operationalise marketing plan

Quality control

File copies of all marketing material in marketing file/soft copy library

Check placement schedule against actual placements

 

STUDENT ENROLLMENT MANAGEMENT

 

Process payment:

Cheque payments, credit card payments and bank deposits

Fax/e-mail acknowledgement of registration

 

VAT INVOICE MANAGEMENT

 

Request VAT invoice from Financial Department

Distribution of VAT invoice

 

STUDY MATERIAL MANAGEMENT

 

Enter quote of printing into P&L

Provide master copy to printer

Diarise deadline for material delivery & inform printer

File master copy on soft copy library

Order study material for faculty, students and assessor

Distribute study material 6 weeks prior to course

Follow- up receipt of study material with students

 

WORKSHOP MANAGEMENT

 

Workshop checklist

Venue checklist

Faculty checklist

 

  

8

  

 

SELF ASSESSMENT MANAGEMENT

 

Determine timelines 
Handing in of assignments 
Receiving back from assessor 
Diarise timelines 
Receive assignments 
Record receipt of assignment in database plus date 
Follow-up outstanding assignments 
Send to assessor 
Receive back from assessor 
Enter marks in database 
Enter evaluation sheets in computer 
Send copies of evaluation to:

Course co-ordinator

Faculty

Stakeholders

Analyse evaluation

Discuss changes with relevant stakeholders 
File evaluation sheet in soft copy library 
Evaluate marketing methodology 
Ensure that initial set has been developed 
File in soft copy library 
Complete attendance certificates – student information 
Complete CPD certificates based on timesheet 
Send attendance certificate to student 
Send CPD certificate and VAT invoice to students 
File timesheets in master file

 

EXPENDITURE MANAGEMENT

 

Enter P + L into financial management system

Enter all expenses into financial system

Follow up outstanding expenses

Follow up outstanding income

Inform all partners of any divergence with budget

 

ALUMNI MANAGEMENT

 

File database on softcopy library

Archive all documents

 

  

9

  

 

ANNEXURE C

Brain Chemistry Optimization Program – Clinical Practice

 

Level 1: “Biochemistry, Behaviour and Wellbeing”

 

	 	
A.

	
Training Program Outline

 

·      The Value of Understanding Biochemistry

 

·      A scientifically –based, Biochemical Model of Behaviour

 

·      Methods to recharge Brain Chemistry and Harness the Source of Power in Our Brain

 

·      Understanding Physiological Reward Centres vs. Psychological Reward Systems

 

·      Practical Ways to Use Biochemical Profiling with Clients

 

	 	
B.

	
Learning Objectives

 

Participants will acquire q working knowledge of the basic science of brain chemistry and the symbiotic effect of behaviour and be able to apply it to appropriate patient/client treatment protocols.  The Robertson Model of Behaviour will be examined and participants will demonstrate applied theory through the hands-on interpretation and application of a Brain Chemistry Optimization Profile (BCOP), a scientifically –based physiological symptom assessment tool, developed and supported by the Robertson Wellness LLC.  Integrating this tool in the clinical setting will allow the professional participant to deduce more accurate diagnosis, differentiate between optimal treatment methods by analysing principal causes of commercial imbalances, and implement individualized treatment plans proven to maximize patient compliance.  Participants will be able to discuss and explain, in layman’s terms, the scientific basis of renewed hope for behavioural change.

 

	 	
C.

	
Performance Statements

 

Participants will demonstrate their understanding of the use and application of the BCOP assessment tool, of the lecture content and the BCOP Training Manual through the use of a multiple choice and fill-in examination.

 

	 	
D.

	
Advanced Degrees

 

Advanced-degree professionals serving the mental health of individuals who have participated in Level 1 training will have the opportunity to extend their knowledge and become a direct affiliate of Robertson Wellness through additional levels of training.  The program/s will expand on level 1 and dive deeper into the brain, behaviour, mood, and wellbeing.  In addition, more hands on delivery of tool in clinical is provided by Robertson Wellness to assist in renewed hope for behavioural change and maximize patient compliance.

 

	 	
E.

	
On-going Certification

 

Each certified professional is held to specific requirements to maintain certification within the two year certified period.  In addition each certified professional is required to renew certification every two years. If requirements are not met or recertification does not occur before current certification expires, the professional is required to repeat the full training.

 

  

10

  

 

Performance Enhancement Program – Corporate Practice

 

Robertson Wellness offers a decisively different approach toward improving personal performance, health and wellness, utilizing the science of brain chemistry.  The Robertson Wellness Brain Chemistry Model, on which the Performance Enhancement Programs are founded, is proven, unique research technology based on over 20 years of clinical research and assessments of more than 14,000 people. The Performance Enhancement Programs were instituted by Dr. Joel C. Robertson, Pharm. D., specifically for the betterment of individuals and as a tool to assist individuals in reaching their peak performance at work, home and play.  With over 287,000 variables, our individualized plans incorporate medically recognized studies on how brain chemicals can be affected to promote healthier behaviors and thought patterns.  We know our techniques are successful because 87 percent of people who have gone through our programs over the last twenty years have reported improvement in areas such as addictions control, mood stabilization, interpersonal relationships, weight management, self-esteem, stress and anxiety management, problem-solving and overall performance.

Level 1: “Maximizing Personal Health and Performance: Through Brain Chemistry Technology”

 

	 	
A.

	
Training Program Outline

 

·      The Brains Influence on Overall Health

 

·      The Four Concepts of Brain Health and Brain Chemistry

 

·      Harnessing the Source of Power in Our Brain

 

·      Understanding the Performance Enhancement Program

 

·      Enhancing the Corporate Executive

 

	 	
B.

	
Learning Objectives

 

Participants will acquire a working knowledge of the basic science of brain chemistry and behaviour.  The Robertson Model of Behaviour will be examined and participants will demonstrate applied theory through the hands-on interpretation and application of a Performance Enhancement Program (PEP), This Performance Enhancement evaluation will provide the professional with methods to maximize an individual’s brain including dietary, nutritional, activity, exercise, and behavioural techniques that are “prescribed” for the particular individual.

 

Additionally the professional will be able to work with the individual to learn more about their own creativity--are they more effective in a group or alone? When are they most efficient, and for what task? Should they work within a detail environment, or are they better adapted to developing creative long range plans? The professional will have working knowledge that these and other factors are determined in part by the person’s physiology. Individuals working in environments that are not consistent with their biochemistry will burn out and become negatively affected by stress in all areas of their lives.

 

  

11

  

 

	 	
C.

	
Performance Statements

 

Participants will demonstrate their understanding of the use and application of the PEP assessment tool, of the lecture content through the use of a multiple choice and fill-in examination.

 

	 	
D.

	
Advanced Degrees

 

Advanced-degree professionals serving the health of individuals who have participated in Level 1 training will have the opportunity to extend their knowledge through additional levels of training. The program/s will expand on level 1 and dive deeper into the understanding neuro-physiology, team productivity and enhancement, and corporate wellness expansion.  In addition, more hands on delivery of tool in corporate practice is provided by Robertson Wellness to assist in renewed hope for maximum individual and team performance and maximize compliance.

 

	 	
A.

	
On-going Certification

 

Each certified professional is held to specific requirements to maintain certification within the two year certified period.  In addition each certified professional is required to renew certification every two years. If requirements are not met or recertification does not occur before current certification expires, the professional is required to repeat the full training.

 

 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]